Glucotrack (GCTK) Accounts Payables (2010 - 2025)

Glucotrack has disclosed Accounts Payables across 16 years of filings, most recently posting $1.3 million for Q4 2025.

• Quarterly Accounts Payables rose 32.76% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 32.76% YoY) and the FY2025 annual result came in at $1.3 million, up 32.76% from the prior year.
• Accounts Payables retreated to $1.3 million in Q4 2025, from $1.7 million in the prior quarter.
• Over five years, Accounts Payables peaked at $2.7 million in Q2 2024 and troughed at $590000.0 in Q1 2022.
• A 5-year average of $1.1 million and a median of $835500.0 in 2023 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2021 — Accounts Payables slumped 50.33% — and 2024, when it jumped 228.85%.
• Tracing GCTK's Accounts Payables over 5 years: stood at $631000.0 in 2021, then climbed by 6.5% to $672000.0 in 2022, then increased by 24.85% to $839000.0 in 2023, then advanced by 18.24% to $992000.0 in 2024, then surged by 32.76% to $1.3 million in 2025.
• Business Quant data shows GCTK's Accounts Payables at $1.3 million in Q4 2025, $1.7 million in Q3 2025, and $2.6 million in Q2 2025.